CARL - Carlsmed, Inc. Common Stock

CARL - Carlsmed, Inc. Common Stock

https://carlsmed.com

Momentum: Bearish

Recent News

Powered by Alpha Vantage

Why Is Carlsmed Stock Gaining Monday? - Carlsmed ( NASDAQ:CARL )

Benzinga • 3 weeks, 6 days ago • score: 0.49

CMS grants NTAP reimbursement of up to $21,125 for Carlsmed's spine implants. BofA forecasts 66% revenue growth in 2025, Buy rating with $16 target. Get the exact trades and sectors to target before August's biggest earnings-driven market moves. Details here → Carlsmed Inc.

This Synaptics Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Monday - Carlsmed ( NASDAQ:CARL ) , Live Nation Entertainment ( NYSE:LYV )

Benzinga • 4 weeks ago • score: -0.02

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page. MoffettNathanson analyst Robert Fishman initiated coverage on Live Nation Entertainment, Inc.

Carlsmed Inc. to Report Second Quarter 2025 Financial Results on August 28, 2025

GlobeNewswire • 1 month ago • score: 0.42

CARLSBAD, Calif., Aug. 14, 2025 ( GLOBE NEWSWIRE ) -- Carlsmed, Inc. ( Nasdaq: CARL ) , a medical technology company pioneering AI-enabled personalized spine surgery solutions, today announced it will report its second quarter 2025 financial results after market close on Thursday, August 28, ...

Carlsmed Inc. to Report Second Quarter 2025 Financial Results on August 28, 2025 - Carlsmed ( NASDAQ:CARL )

Benzinga • 1 month ago • score: 0.38

CARLSBAD, Calif., Aug. 14, 2025 ( GLOBE NEWSWIRE ) -- Carlsmed, Inc. CARL, a medical technology company pioneering AI-enabled personalized spine surgery solutions, today announced it will report its second quarter 2025 financial results after market close on Thursday, August 28, 2025.

Carlsmed's aprevo® Personalized Interbody Implants Receive CMS New Technology Add-On Payment ( NTAP ) for Cervical Fusion Procedures - Carlsmed ( NASDAQ:CARL )

Benzinga • 1 month, 2 weeks ago • score: 0.35

CARLSBAD, Calif., Aug. 01, 2025 ( GLOBE NEWSWIRE ) -- Carlsmed, Inc. ( "Carlsmed" ) , a medical technology company pioneering AI-enabled personalized spine surgery solutions, today announced that in the Hospital Inpatient Prospective Payment Systems Final Rule ( IPPS ) for fiscal year ( FY ) ...

Carlsmed's aprevo® Personalized Interbody Implants Receive CMS New Technology Add-On Payment ( NTAP ) for Cervical Fusion Procedures

GlobeNewswire • 1 month, 2 weeks ago • score: 0.34

CARLSBAD, Calif., Aug. 01, 2025 ( GLOBE NEWSWIRE ) -- Carlsmed, Inc. ( "Carlsmed" ) , a medical technology company pioneering AI-enabled personalized spine surgery solutions, today announced that in the Hospital Inpatient Prospective Payment Systems Final Rule ( IPPS ) for fiscal year ( FY ) ...

Carlsmed's aprevo® Powers First Personalized Cervical Spine Surgery - Carlsmed ( NASDAQ:CARL )

Benzinga • 1 month, 2 weeks ago • score: 0.43

CARLSBAD, Calif., July 28, 2025 ( GLOBE NEWSWIRE ) -- Carlsmed, Inc.

Carlsmed's aprevo® Powers First Personalized Cervical Spine Surgery

GlobeNewswire • 1 month, 2 weeks ago • score: 0.43

CARLSBAD, Calif., July 28, 2025 ( GLOBE NEWSWIRE ) -- Carlsmed, Inc. ( Nasdaq: CARL ) ( "Carlsmed" ) , a medical technology company pioneering AI-enabled personalized spine surgery solutions, today announced the successful completion of the first aprevo® cervical procedure on July 14, 2025 by ...

Interval:

EMA1: EMA2:

AI Tools

Key Metrics

Trend: Downtrend

Source: Snapshot

Carlsmed, Inc. develops and operates a surgical platform for the treatment of complex adult spinal deformities that enables surgeons to harness clinical intelligence, advanced image recognition, and 3D printing technologies. The company is headquartered in Carlsbad, California.

52W High

$15.20

52W Low

$0.00

MA Status:

50D: Below 200D: Below

Beta (~1 neutral, <0.9 lower risk)

N/A

Valuation

Source: Overview

Trailing P/E (<15 better)

N/A

Forward P/E (<15 better)

N/A

EV/EBITDA (<8 favorable)

N/A

EV/Revenue (<3 favorable)

N/A

P/S (TTM) (<3 favorable)

N/A

P/B (<3 favorable)

N/A

Ownership

Source: Overview

Insiders (1–5% typical)

0.00%

Institutions (25–75% balanced)

0.00%

Shares Outstanding

0

Float

0

Dividend Yield (2–6% sweet spot)

N/A

Ex‑Dividend Date

N/A

Income & Growth

Source: Overview

Revenue (TTM)

0

Gross Profit (TTM)

0

EPS (TTM)

N/A

Profit Margin (>10% good)

N/A

Operating Margin (TTM) (higher better)

N/A

ROE (TTM) (>15% strong)

N/A

EPS YoY (Quarterly) (>10% good)

N/A

Revenue YoY (Quarterly) (>8% good)

N/A

Momentum

Bearish momentum

Value

0.1469

Previous

-0.0029

Trend

Rising

Signal Cross

Crossed Up Today

As of

Sep. 12, 2025